Kristoff Muylle

Laarbeeklaan 101
1090 Brussels
Belgium
Laarbeeklaan 101
1090 Jette
Belgium
Pleinlaan 2
1050 Brussel
Belgium
Pleinlaan 2
1050 Brussel
Belgium

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Kristoff Muylle is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

2 Active

EUAR33: H2020: CSA: EURAMED rocc-n-roll: title EURopeAn MEDical application and Radiation prOteCtion Concept: strategic research agenda aNd ROadmap interLinking to heaLth and digitisation aspects
Muylle, K. & Lahoutte, T.
1/09/20 → 31/08/23
Project: Fundamental
OZR3685: H2020: CSA: EURAMED rocc-n-roll: title EURopeAn MEDical application and Radiation prOteCtion Concept: strategic research agenda aNd ROadmap interLinking to heaLth and digitisation aspects (OZR EU BONUS)
Muylle, K.
1/09/20 → 31/08/23
Project: Fundamental

97 Citations
3 h-Index
5 Article
4 Meeting abstract (Journal)
2 Meeting abstract (Book)
1 Commissioned report
More
- 1 Poster

18F-FDG PET/CT findings in an adult with diffuse hemangiomatosis mimicking diffuse metastasis on conventional radiology
Ardies, P. J., Muylle, K., Everaert, H., Goethals, L., Gykiere, P., Keyaerts, M. & Lahoutte, T., 5 May 2017.
Research output: Unpublished contribution to conference › Poster
PET 20.0: a cost-efficient, 2mm spatial resolution Total Body PET with point sensitivity up to 22% and adaptive axial FOV of maximum 2.00m
Vandenberghe, S., Mikhalyova, E., Brans, B., Defrise, M., Lahoutte, T., Muylle, K., Van Holen, R., Schaart, D. R. & Karp, K. S., Oct 2017, In : European Journal of Nuclear Medicine and Molecular Imaging. 44, p. S305-S305
Research output: Contribution to journal › Meeting abstract (Journal)

1 Citation (Scopus)
Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab
Muylle, K., Flamen, P., Vugts, D. J., Guiot, T., Ghanem, G., Meuleman, N., Bourgeois, P., Vanderlinden, B., van Dongen, G. A. M. S., Everaert, H., Vaes, M. & Bron, D., Jul 2015, In : European Journal of Nuclear Medicine and Molecular Imaging. 42, 8, p. 1304-1314 11 p.
Research output: Contribution to journal › Article
39 Citations (Scopus)
Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab.
Muylle, K., Flamen, P., Vugts, DJ., Guiot, T., Ghanem, G., Meuleman, N., Bourgeois, P., Vanderlinden, B., van Dongen, GAMS., Everaert, H., Vaes, M. & Bron, D., 2015, In : European Journal of Nuclear Medicine and Molecular Imaging. 42, p. 1304-1314
Research output: Contribution to journal › Article
Radionuclide Therapy for Symptomatic Prostate Cancer in Castration-Resistant Prostate Cancer Patients with 223RaCl2
Covens, P., Jamar, F. & Muylle, K., Mar 2014, HGR/CSS ed. FOD Volksgezonheid, Veiligheid van de voedselketen en leefmilieu. 15 p.
Research output: Book/Report › Commissioned report › Research

Open Access

1 Other
1 Talk or presentation at a conference

2020-75
Tony Lahoutte (Supervisor), Kristoff Muylle (Contributor)
2020
Activity: Other
2017 BELNUC Highlights Lecture
Kristoff Muylle (Invited speaker)
7 May 2017
Activity: Talk or presentation › Talk or presentation at a conference